Table 5.
The association between different clinicopathological parameters and immuno-nutritional scores.
| Parameters | HALP Score | PNI SCORE | ||||
|---|---|---|---|---|---|---|
| Low | High | p-Value 1 | Low | High | p-Value 1 | |
| Clinical stage, n (%) | ||||||
| Stage I | 30 (20) | 118 (80) | <0.0001 * | 12 (8) | 136 (92) | <0.0001 * |
| Stage II + III | 27 (49) | 30 (51) | 16 (29) | 39 (71) | ||
| Tumor size, n (%) | ||||||
| <4 cm | 26 (21) | 100 (79) | 0.004 * | 9 (7) | 117 (93) | <0.0001 * |
| >4 cm | 25 (40) | 37 (60) | 16 (26) | 46 (74) | ||
| BMI, n (%) | ||||||
| <30 kg/m2 | 52 (31) | 116(69) | 0.124 | 24 (14) | 144 (86) | 0.759 |
| >30 kg/m2 | 4 (16) | 21 (84) | 3 (12) | 22 (88) | ||
| LVI, n (%) | ||||||
| No | 25 (27) | 68 (73) | 0.509 | 15 (16) | 78 (84) | 0.476 |
| Yes | 30 (31) | 66 (69) | 12 (13) | 84 (87) | ||
| Multifocality, n (%) | ||||||
| Yes | 11 (34) | 21 (66) | 0.471 | 20 (13) | 137 (87) | 0.178 |
| No | 44 (28) | 113 (72) | 7 (22) | 25 (78) | ||
HALP-hemoglobin, albumin, lymphocytes and platelets score (formula: hemoglobin × albumin × lymphocytes/platelets); PNI-prognostic nutritional index (formula: albumin + 0.0005 × lymphocytes); BMI-body mass index, LVI-lymphovascular invasion; High HALP score > 42.56; high PNI score >52.5; 1 χ2 test; * p < 0.05.